Dual Deletion of Keap1 and Rbpjκ Genes in Liver Leads to Hepatomegaly and Hypercholesterolemia
Nobunao Wakabayashi, Yoko Yagishita, Tanvi Joshi, Thomas W. Kensler

TL;DR
Deleting two genes in mice livers causes liver enlargement and high cholesterol, worsening liver damage due to disrupted signaling pathways.
Contribution
Dual gene deletion reveals unexpected exacerbation of liver disease through imbalanced NOTCH and NRF2 signaling.
Findings
Dual deletion of Keap1 and Rbpjκ worsens hypercholesterolemia and cholestatic liver damage in mice.
NRF2 signaling changes gene expression in cholesterol and bile acid pathways, increasing liver cholesterol.
Reduced Cyp1A7 and Abcb11 gene expression weakens bile acid homeostasis in compound mutant mice.
Abstract
The hepatic deletion of Rbpjκ (RbpjF/F::AlbCre) in the mouse leads to exhibition of the Alagille syndrome phenotype during early postnatal liver development with hyperlipidemia and cholestasis due to attenuated disruption of NOTCH signaling. Given the roles of NRF2 signaling in the regulation of lipid metabolism and bile ductal formation, it was anticipated that these symptoms could be alleviated by enhancing NRF2 signaling in the RbpjF/F::AlbCre mouse by hepatic deletion of Keap1 in compound Keap1F/F::RbpjF/F::AlbCre mice. Unexpectedly, these mice developed higher hepatic and plasma cholesterol levels with more severe cholestatic liver damage during the pre-weaning period than in the RbpjF/F::AlbCre mice. In addition, hypercholesterolemia and hepatic damage were sustained throughout the growth period unlike in the RbpjF/F::AlbCre mouse. These enhanced abnormalities in lipid metabolism…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsDrug Transport and Resistance Mechanisms · Liver Disease Diagnosis and Treatment · Pediatric Hepatobiliary Diseases and Treatments
